Search

Your search keyword '"Coggins, Matthew"' showing total 78 results

Search Constraints

Start Over You searched for: Author "Coggins, Matthew" Remove constraint Author: "Coggins, Matthew" Search Limiters Full Text Remove constraint Search Limiters: Full Text
78 results on '"Coggins, Matthew"'

Search Results

1. Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome (NODRS)

2. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

3. De novo variants in DENND5B cause a neurodevelopmental disorder

4. Clinical application of a scale to assess genomic healthcare empowerment (GEmS): Process and illustrative case examples

5. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

6. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

7. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

8. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

9. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

10. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

11. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

12. De novo variants in DENND5B cause a neurodevelopmental disorder

13. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

14. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

15. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

16. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

17. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

18. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

19. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

20. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

21. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

22. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

23. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

24. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

25. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

26. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

27. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

29. Phenotypic Characterization of Individuals With Variants in Cardiovascular Genes in the Absence of a Primary Cardiovascular Indication for Testing

30. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

31. Variants in PRKAR1Bcause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

32. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

33. An autosomal dominant neurological disorder caused by de novo variants in FAR1resulting in uncontrolled synthesis of ether lipids

35. Obesity Blunts Insulin's Action to Recruit Capillaries in Human Skeletal Muscle

36. De novo variants in MRTFBhave gain-of-function activity in Drosophilaand are associated with a novel neurodevelopmental phenotype with dysmorphic features

Catalog

Books, media, physical & digital resources